ARS Presidential Address: Estrogen therapy: a causal role in endometrial cancer?

Authors:
  • FRFn Rutledge
    Fn Rutledge
  • TBTw Broderick
    Tw Broderick
  • RRRt Reinke
    Rt Reinke
  • EGE Goldman
    E Goldman
  • EMEJ McDonald
    EJ McDonald
  • JMJm Malone
    Jm Malone
  • RERl Eisenberg
    Rl Eisenberg
  • RMRl Mani
    Rl Mani
  • RSRm Steiner
    Rm Steiner
  • MKM Kricun
    M Kricun
  • JSJ Shapiro
    J Shapiro
  • YBYm Berkmen
    Ym Berkmen

Abstract
Publicity associated with recent reports of a greater frequency of adenocarcinoma of the endometrium among women who take exogenous estrogens has created confusion among physicians and fear among patients. An objective review of available data on estrogen effects and current epidemiologic evidence suggests that estrogen may play an indirect role in the development of endometrial carcinoma. Until definitive data are available, physicians should exercise caution in prescribing estrogens, monitoring the status of the endometrium at regular intervals by sampling and pathologic analysis.